Back to Trades
Rangwala Reshma
InsiderCIK 0001825322
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 2
- Buy transactions
- 0
- Sell transactions
- 2
- Companies
- 1
- Active
- 2025–2026
Rangwala Reshma has filed 2 SEC reports (2025–2026), all concentrated in Karyopharm Therapeutics Inc. (KPTI), totaling $50.3K in disclosed volume. Weighing $0 bought versus $50.3K sold, the history is heavily weighted toward selling. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
2 loaded
| Mar 3 | KPTI Karyopharm Therapeutics Inc. | Rangwala Reshma | Insider | Sell | $47.7K |
| Sep 16 | KPTI Karyopharm Therapeutics Inc. | Rangwala Reshma | Insider | Sell | $2.6K |
2 filings